Tower Research Capital LLC (Trc) Nektar Therapeutics Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.42 - $0.57 $5,172 - $7,019	-12,315 Reduced 54.49%	10,284 $5,000
Q3 2023 Nov 14, 2023	SELL	$0.51 - $1.05 $11,835 - $24,367	-23,207 Reduced 50.66%	22,599 $13,000
Q2 2023 Aug 14, 2023	BUY	$0.53 - $1.03 $2,521 - $4,900	4,758 Added 11.59%	45,806 $26,000
Q1 2023 May 09, 2023	BUY	$0.64 - $3.15 $19,367 - $95,322	30,261 Added 280.53%	41,048 $29,000
Q4 2022 Feb 10, 2023	SELL	$2.03 - $4.28 $7,675 - $16,182	-3,781 Reduced 25.95%	10,787 $24,000

Q3 2022 Nov 10, 2022	BUY	$3.04 - $5.14 $19,936 - $33,708	6,558 Added 81.87%	14,568 $47,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $13,719 - $26,703	4,328 Added 117.54%	8,010 $31,000
Q1 2022 May 12, 2022	SELL	$4.16 - $13.72 $4,447 - $14,666	-1,069 Reduced 22.5%	3,682 $20,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $74,640 - $126,881	-6,892 Reduced 59.19%	4,751 $64,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $627 - $904	-48 Reduced 0.41%	11,643 $209,000
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $31,388 - $38,760	1,900 Added 19.41%	11,691 $201,000
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $92,421 - $142,092	-5,581 Reduced 36.31%	9,791 $196,000
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $152,511 - $184,039	9,671 Added 169.64%	15,372 $261,000
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $849,291 - $1.27 Million	-51,193 Reduced 89.98%	5,701 $95,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $944,497 - $1.31 Million	56,020 Added 6409.61%	56,894 $1.32 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $120,535 - $232,906	-8,330 Reduced 90.5%	874 $16,000
Q4 2019 Feb 07, 2020	BUY	$15.87 - $23.12 $8,363 - $12,184	527 Added 6.07%	9,204 $199,000
Q3 2019 Nov 05, 2019	BUY	$16.91 - $36.27 $143,143 - $307,025	8,465 Added 3992.92%	8,677 $158,000
Q2 2019 Aug 13, 2019	SELL	$31.0 - $36.3 $257,176 - $301,144	-8,296 Reduced 97.51%	212 $8,000
Q1 2019 May 14, 2019	BUY	$31.58 - $46.35 $136,488 - $200,324	4,322 Added 103.25%	8,508 $285,000
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $127,379 - $237,136	4,186 New	4,186 $138,000
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $84,231 - $124,172	-1,813 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$46.25 - $104.45 $83,851 - $189,367	1,813 New	1,813 $89,000
Q4 2017 Feb 09, 2018	SELL	$23.02 - $60.5 $389,475 - $1.02 Million	-16,919 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $300,989 - $406,056	16,919	16,919 $406,000

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$22.8 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.9 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$9.39 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.64 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$7.29 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $232M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account